Transparency Market Research
Commercial Fuel Cards Market is Predicted to Reach USD 230.9 billion at a CAGR of 4.2% by 2031 - Report by Transparency Market Research Inc.
November 14, 2023 03:17 ET | Transparency Market Research
Wilmington, Delaware, United States, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global North America commercial fuel cards market is projected to flourish at a CAGR of...
Research Nester Logo.jpg
Gabapentin Market revenue to reach USD 6 Billion by 2035, says Research Nester
August 29, 2023 06:00 ET | Research Nester
New York, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The gabapentin market size is poised to grow at a CAGR of over ~ 5 % from 2023 to 2035. The market is anticipated to garner a revenue of USD 6 billion by...
cmi_logo.png
[Latest] Global In CAR Audio System Market Size/Share Worth USD 25.62 Billion by 2032 at a 11% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 05, 2023 14:35 ET | Custom Market Insights
Austin, TX, USA, July 06, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “IIn CAR Audio System Market Size, Trends and Insights By Component (Speaker,...
Industry First: New
Industry First: New Tech Platform To Help Brand Acquisition Companies Identify and Acquire Their Next Winning Brand
July 07, 2021 07:30 ET | Perpetua Labs
SAN FRANCISCO, July 07, 2021 (GLOBE NEWSWIRE) -- San Francisco (July 7, 2021) — Perpetua, a global leader in eCommerce advertising and intelligence software announces the launch of Perpetua's Brand...
Graphical Research.jpg
Antiviral Drugs Market Size & Share | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
April 12, 2021 06:00 ET | Graphical Research
Pune, India, April 12, 2021 (GLOBE NEWSWIRE) -- The global antiviral drugs market size is anticipated to witness accelerated growth during the forecast period due to the growing focus toward...
L'activité de commer
L'activité de commercialisation de cannabis de qualité supérieure au Québec d'Emerald Health Therapeutics reçoit une modification de licence permettant la vente directe de produits de marque
October 16, 2019 10:12 ET | Emerald Health Therapeutics Inc.
VANCOUVER, Colombie-Britannique, 16 oct. 2019 (GLOBE NEWSWIRE) -- Verdélite, le site de production de cannabis détenu à 100 % par Emerald Health Therapeutics (« Emerald »)(TSXV : EMH ; OTCQX :...
Emerald Health Thera
Emerald Health Therapeutics’ Québec Premium Cannabis Operation Receives Sale License Amendment, Allowing Direct Sales of Branded Products
October 16, 2019 07:00 ET | Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics’ (“Emerald”)(TSXV: EMH; OTCQX: EMHTF) wholly-owned production facility, Verdélite, in St. Eustache, Québec,...
download-2.png
Pure Sunfarms, la coentreprise d'Emerald Health Therapeutics, commence à expédier ses produits de marque à base de cannabis à un grossiste de la province de la Colombie-Britannique
October 04, 2019 18:38 ET | Emerald Health Therapeutics Inc.
VANCOUVER, Colombie-Britannique, 04 oct. 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF), a annoncé aujourd'hui que sa coentreprise détenue à...
download-2.png
Emerald Health Therapeutics’ Joint Venture Pure Sunfarms Begins Shipping Branded Cannabis Product to British Columbia Provincial Wholesaler
October 04, 2019 07:02 ET | Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), today announced its 50%-owned joint venture for large-scale,...
download-2.png
Emerald Health Therapeutics’ Joint Venture Pure Sunfarms Launches Branded Product Line, Introducing Eight Products for the Recreational Market, and Begins Shipping to Ontario Cannabis Store
September 16, 2019 17:00 ET | Emerald Health Therapeutics Inc.
VANCOUVER, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), today announced that its 50%-owned joint venture for large-scale, low-cost,...